LIVN (LivaNova) NonCurrent Deferred Liabilities: $7 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LIVN LivaNova PLC LIVN
74 GF Score
Price $81.75
GF Value $62.61
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is LivaNova NonCurrent Deferred Liabilities?

LivaNova LIVN +3.00% 74 NonCurrent Deferred Liabilities is $7 Mil as of Mar. 2026. GuruFocus rates LIVN with a GF Score™ of 74/100 and a GF Value™ of $62.61 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

LivaNova's non-current deferred liabilities for the quarter that ended in Mar. 2026 was $7 Mil.

LivaNova NonCurrent Deferred Liabilities Related Terms

LivaNova NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for LivaNova's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LivaNova NonCurrent Deferred Liabilities Chart

LivaNova Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.73 8.52 11.57 10.92 9.59

LivaNova Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.63 11.39 10.10 9.59 6.81
LIVN
74GF Score
LivaNova PLC LIVN
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $7 Mil mean?
LivaNova (LIVN) has a NonCurrent Deferred Liabilities of $7 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on LivaNova and its competitors.
Is LivaNova's NonCurrent Deferred Liabilities too high?
LivaNova's current NonCurrent Deferred Liabilities is $7 Mil. Overall, LivaNova has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LivaNova's NonCurrent Deferred Liabilities compare to IRTC and HAE?
LivaNova's NonCurrent Deferred Liabilities of $7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on LivaNova and its competitors. LivaNova's current NonCurrent Deferred Liabilities is $7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LivaNova stock overvalued right now?
Based on GuruFocus' analysis, LivaNova (LIVN) is currently considered Significantly Overvalued. The stock's GF Value™ is $62.61, compared to a current price of $81.75 — trading 30.6% above its estimated fair value. The current NonCurrent Deferred Liabilities is $7 Mil. LivaNova's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For LivaNova (LIVN), the current NonCurrent Deferred Liabilities is $7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LivaNova (LIVN) Overvalued in 2026?

Based on GuruFocus' analysis, LivaNova stock appears to be overvalued. The current stock price of $81.75 is trading 30.6% above its estimated GF Value™ of $62.61. GuruFocus considers LivaNova to be Significantly Overvalued.

Key valuation signals for LIVN:

  • NonCurrent Deferred Liabilities: $7 Mil
  • GF Value™: $62.61 vs. price of $81.75 (30.6% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the LIVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LivaNova Business Description

Other Exchanges LIA:Germany
Address 20 Eastbourne Terrace, London, GBR, W2 6LG
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
74GF Score

Get the complete analysis for LIVN

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$81.75
Price
$62.61
GF Value